Portfolio company
Nanofacile
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
Nanofacile produces a microfluidic platform and kits for lipid nanoparticle formulation to assist researchers and pharmaceutical companies with ribonucleic acid therapy development.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Inside Therapeutics
The company develops microfluidic instruments for encapsulating therapeutic RNA into lipid nanoparticles for pharmaceutical researchers and nanomedicine manufacturers.
Leon Nanodrugs
This company develops nanoencapsulation equipment for the production of lipid nanoparticles, serving pharmaceutical and biotechnology firms focused on cell and gene therapies.
RNAnalytics
This company develops modular analysis toolkits and software for lipid nanoparticle characterisation to support biotech and pharmaceutical firms developing RNA-based therapies.
NANOLYZE
This company develops waveguide microscopy equipment for real-time analysis of nanoparticles to support researchers in drug development and nanomedicine.
Adalid Science
Adalid Sciences develops lipid nanoparticle delivery systems for nucleic acid therapeutics, serving pharmaceutical companies, biotechnology start-ups, and contract development and manufacturing organisations.
Breeze
This company develops polymer nanoparticles to enable the non-viral delivery of RNA therapeutics to extrahepatic tissues for biotechnology and pharmaceutical organisations.
ExcepGen
ExcepGen develops a platform for nucleic acid therapeutics to improve the efficacy and tolerability of mRNA-based medicines for biopharmaceutical companies.
Nutcracker Therapeutics
The company develops an automated microfluidic platform for manufacturing mRNA-based therapeutics and vaccines for pharmaceutical partners and medical researchers.
